Recludix Pharma
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$248M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Recludix Pharma is a biotechnology company that develops innovative small-molecule inhibitors for challenging protein targets to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recludix Pharma Comparables
Compare Recludix Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BridgeBio Pharma, Inc. | 81% | |
| Erasca | 80% | |
| Revolution Medicines | 80% |
Recludix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Strategic | Jul 20, 2023 | ||||
| Series A | Nov 15, 2021 |
Key People
Founding team and executive leadership
Recludix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Westlake Village BioPartners | Series A, Series B |
| New Enterprise Associates | Series A, Series B |
| Alexandria Venture Investments | Series B |
| Access Biotechnology | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 49% MoM.
- Mar 16, 2026
Catherine Bovenizer promoted to Chief Financial Officer.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
Recludix Pharma, Inc. will attend event Stifel 2026 Virtual Immunology and Inflammation Forum on Sep 24th '26.
Recludix Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Recludix Pharma's valuation, stock price, and market status.
Is Recludix Pharma a public or private company?
Recludix Pharma is a private company.
What is the current stock price of Recludix Pharma?
Recludix Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Recludix Pharma worth (valuation)?
Valuation information for Recludix Pharma is not publicly available.
Can I buy Recludix Pharma stock?
Recludix Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Recludix Pharma's last funding round?
Recludix Pharma's most recent funding round was Strategic on July 20, 2023.
Who are the main investors in Recludix Pharma?
Key investors in Recludix Pharma include Access Industries, Westlake Village Biopartners.
Will Recludix Pharma IPO soon?
No public IPO plans have been announced for Recludix Pharma.
How can I track Recludix Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Recludix Pharma's secondary market activity and sign up for updates.